Drugs / Multipeptide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04842513 | May 2021 → Jul 2024 | brain glioblastoma | University Hospital Tuebingen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Multipeptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04842513 ↗ |
| Modality | Vaccine | “Multi peptide vaccination” NCT04842513 ↗ |